C40B 30/06
Methods of screening libraries: by measuring effects on living organisms, tissues or
Official title: by measuring effects on living organisms, tissues or cells
C40B30/06 (Methods of screening libraries: by measuring effects on living organisms, tissues or) appears on 147 US grants and 325 published applications in this corpus.
Search patents in C40B- Granted patents
- 147
- Published applications
- 325
- Assignees
- 198
- Inventors
- 789
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 3 |
| 2003 | 0 | 1 |
| 2004 | 3 | 5 |
| 2005 | 2 | 3 |
| 2006 | 0 | 4 |
| 2007 | 3 | 4 |
| 2008 | 3 | 8 |
| 2009 | 2 | 14 |
| 2010 | 1 | 6 |
| 2011 | 3 | 9 |
| 2012 | 0 | 8 |
| 2013 | 3 | 5 |
| 2014 | 5 | 9 |
| 2015 | 6 | 4 |
| 2016 | 11 | 8 |
| 2017 | 6 | 3 |
| 2018 | 5 | 13 |
| 2019 | 6 | 32 |
| 2020 | 9 | 36 |
| 2021 | 15 | 27 |
| 2022 | 10 | 34 |
| 2023 | 23 | 37 |
| 2024 | 9 | 27 |
| 2025 | 10 | 9 |
| 2026 | 11 | 16 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Detection and prediction of infectious disease6 Oct 2026US 12,753,448 B2Karius, Inc.
- Discovery and evolution of biologically active metabolites8 Sep 2026US 12,729,458 B2The Regents of the University of Colorado, a body corporate
- Randomized configuration targeted integration of nucleic acids8 Sep 2026US 12,729,459 B2Genentech, Inc.
- Method of identifying intracellular secretory protein or tissue-specific secretory protein28 Jul 2026US 12,692,627 B2Korea Advanced Institute of Science and Technology
- High throughput method for constructing and screening compound library and reaction device14 Jul 2026US 12,681,007 B2Deepsyn. Co
- Composition and method for bacteriophage susceptibility screening24 Sep 2026US 2026/0286417 A1McMaster University
- Macrocyclic modulators of disease associated protein misfolding and aggregation6 Aug 2026US 2026/0226658 A1Resq Biotech
- Improved method and system for determining efficacies for one or more pharmaceutical drugs for a plurality of medical indications6 Aug 2026US 2026/0227385 A1PreComb Therapeutics AG
- Screening culture medium and screening method23 Jul 2026US 2026/0209817 A1Teikyo University
- Sidewinder three-way junction dna assembly9 Jul 2026US 2026/0193813 A1
Most cited
By later US patents
- System for seizure suppression90US 7,892,764 B2Legacy Emanuel Hospital & Health Center · 2011
- Protease-resistant systems for polypeptide display and methods of making and using thereof29US 9,309,510 B2CytomX Therapeutics, Inc. · 2016
- Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells20US 7,632,972 B2The Board of Trustees of the University of Illionis · 2009
- Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies20US 8,440,798 B2Cancer Research Technology Limited · 2013
- Normalized nucleic acid libraries and methods of production thereof19US 6,399,334 B1Invitrogen Corporation · 2002